Graham McClelland, PhD


Are New Medicines Being Developed to Meet the Needs of the Ever-Ageing Population?

February 28, 2020

The elderly population is still underrepresented in clinical trials, with nearly a third of newly registered drugs included an insufficient number of elderly participants, leading to uncertainties regarding safety and effectiveness for prescribers.